122 related articles for article (PubMed ID: 31892567)
1. Circulating Tumor DNA in Saliva in an Orthotopic Head and Neck Cancer Mouse Model.
Eun YG; Yoon YJ; Won KY; Lee YC
Anticancer Res; 2020 Jan; 40(1):191-199. PubMed ID: 31892567
[TBL] [Abstract][Full Text] [Related]
2. Blood and saliva-derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus-associated head and neck cancer.
Ferrier ST; Tsering T; Sadeghi N; Zeitouni A; Burnier JV
Cancer Med; 2023 Aug; 12(15):15777-15787. PubMed ID: 37526056
[TBL] [Abstract][Full Text] [Related]
3. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
[TBL] [Abstract][Full Text] [Related]
4. Cell-Free DNA Kinetics in a Pre-Clinical Model of Head and Neck Cancer.
Muhanna N; Di Grappa MA; Chan HHL; Khan T; Jin CS; Zheng Y; Irish JC; Bratman SV
Sci Rep; 2017 Dec; 7(1):16723. PubMed ID: 29196748
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D
Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887
[TBL] [Abstract][Full Text] [Related]
6. Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA).
Gasparello J; Allegretti M; Tremante E; Fabbri E; Amoreo CA; Romania P; Melucci E; Messana K; Borgatti M; Giacomini P; Gambari R; Finotti A
J Exp Clin Cancer Res; 2018 Jun; 37(1):124. PubMed ID: 29941002
[TBL] [Abstract][Full Text] [Related]
7. Serum, plasma and saliva biomarkers for head and neck cancer.
Arantes LMRB; De Carvalho AC; Melendez ME; Lopes Carvalho A
Expert Rev Mol Diagn; 2018 Jan; 18(1):85-112. PubMed ID: 29134827
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal detection of somatic mutations in saliva and plasma for the surveillance of oral squamous cell carcinomas.
Cui Y; Kim HS; Cho ES; Han D; Park JA; Park JY; Nam W; Kim HJ; Cha IH; Cha YH
PLoS One; 2021; 16(9):e0256979. PubMed ID: 34478472
[TBL] [Abstract][Full Text] [Related]
9. Liquid Biopsy in Head and Neck Cancer: Promises and Challenges.
Nonaka T; Wong DTW
J Dent Res; 2018 Jun; 97(6):701-708. PubMed ID: 29513618
[TBL] [Abstract][Full Text] [Related]
10. A liquid biopsy for head and neck cancers.
Schmidt H; Kulasinghe A; Perry C; Nelson C; Punyadeera C
Expert Rev Mol Diagn; 2016; 16(2):165-72. PubMed ID: 26631411
[TBL] [Abstract][Full Text] [Related]
11. Tissue expression, serum and salivary levels of IL-10 in patients with head and neck squamous cell carcinoma.
Hamzavi M; Tadbir AA; Rezvani G; Ashraf MJ; Fattahi MJ; Khademi B; Sardari Y; Jeirudi N
Asian Pac J Cancer Prev; 2013; 14(3):1681-5. PubMed ID: 23679256
[TBL] [Abstract][Full Text] [Related]
12. Pre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrence.
Isaksson S; George AM; Jönsson M; Cirenajwis H; Jönsson P; Bendahl PO; Brunnström H; Staaf J; Saal LH; Planck M
Acta Oncol; 2019 Aug; 58(8):1079-1086. PubMed ID: 31230502
[No Abstract] [Full Text] [Related]
13. Circulating Non-Coding RNAs in Head and Neck Cancer: Roles in Diagnosis, Prognosis, and Therapy Monitoring.
Diez-Fraile A; Ceulaer J; Derpoorter C; Spaas C; Backer T; Lamoral P; Abeloos J; Lammens T
Cells; 2020 Dec; 10(1):. PubMed ID: 33396240
[TBL] [Abstract][Full Text] [Related]
14. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
Franzmann EJ; Schroeder GL; Goodwin WJ; Weed DT; Fisher P; Lokeshwar VB
Int J Cancer; 2003 Sep; 106(3):438-45. PubMed ID: 12845686
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.
Righini CA; de Fraipont F; Timsit JF; Faure C; Brambilla E; Reyt E; Favrot MC
Clin Cancer Res; 2007 Feb; 13(4):1179-85. PubMed ID: 17317827
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients.
Rettori MM; de Carvalho AC; Bomfim Longo AL; de Oliveira CZ; Kowalski LP; Carvalho AL; Vettore AL
Carcinogenesis; 2013 Jan; 34(1):20-7. PubMed ID: 23042095
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor DNA dynamics analysis in a xenograft mouse model with esophageal squamous cell carcinoma.
Terasawa H; Kinugasa H; Nouso K; Yamamoto S; Hirai M; Tanaka T; Takaki A; Okada H
World J Gastroenterol; 2021 Nov; 27(41):7134-7143. PubMed ID: 34887633
[TBL] [Abstract][Full Text] [Related]
18. Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery.
Ng SB; Chua C; Ng M; Gan A; Poon PS; Teo M; Fu C; Leow WQ; Lim KH; Chung A; Koo SL; Choo SP; Ho D; Rozen S; Tan P; Wong M; Burkholder WF; Tan IB
Sci Rep; 2017 Jan; 7():40737. PubMed ID: 28102343
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor DNA in the saliva of patients with head and neck cancer: A pilot report.
Lee YC; Kim SI; Kwon H; Bae JS; Lee S
Oral Dis; 2021 Sep; 27(6):1421-1425. PubMed ID: 33073423
[No Abstract] [Full Text] [Related]
20. Tumor-Associated Endothelial Cells Promote Tumor Metastasis by Chaperoning Circulating Tumor Cells and Protecting Them from Anoikis.
Yadav A; Kumar B; Yu JG; Old M; Teknos TN; Kumar P
PLoS One; 2015; 10(10):e0141602. PubMed ID: 26509633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
